Conexeu Sciences IncCNXU
Price$3.32

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Margins

Current

Balance Sheet Health

Current Ratio5.31x
Cash & Equivalents$2M

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics$0
View details

Targeting initial 510(k) submission in Q1 2027 for wound care, followed by planned expansion into the medical aesthetics market.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.